Half the patients in a clinical trial were able to safely stop immunosuppressant medication following a modified blood stem cell transplant for severe sickle cell disease, according to a study conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
About 7 days after conception, something remarkable occurs in the clump of cells that will eventually become a new human being. They start to specialize into any of the roughly 200 cell types that exist in people.
Two men with HIV may have been cured after they received stem cell transplants to treat lymphoma, a type of blood cancer.
Researchers have identified a way to enhance regrowth of human corneal tissue to restore vision, using a molecule known as ABCB5 that acts as a marker for hard-to-find limbal stem cells.
Osiris Therapeutics, Inc., has announced that a report of the results of its multicenter randomized, controlled clinical trial comparing the safety and effectiveness of Grafix to control in patients with chronic diabetic foot ulcers (DFUs) has been accepted for publication in the Internationa
Scientists have discovered a new class of lipids in leukemia cells that are detected by a unique group of immune cells. By recognizing the lipids, the immune cells stimulate an immune response to destroy the leukemia cells and suppress their growth.
Calimmune has been given the go ahead to treat a second group of patients in a phase I/II clinical trial testing its gene-based stem cell therapy for HIV.
The company was given the green light to move ahead following a review of safety data by the Data Safety Monitoring Board (DSMB).
An EU-funded project called “VascuBone” that is focused on alternative solutions for treating bone defects is heading full speed into its final months of development.
The secret of how salamanders successfully regrow body parts is being unraveled by researchers in a bid to apply it to humans.
New research suggests that the diversity of bacteria in the gastrointestinal tract of patients receiving stem cell transplants may be an important predictor of their survival.